- Report
- January 2025
- 142 Pages
Asia Pacific
From €2865EUR$3,250USD£2,499GBP
- Report
- October 2025
- 150 Pages
Middle East
From €5246EUR$5,950USD£4,575GBP
- Report
- September 2025
- 150 Pages
Middle East
From €4364EUR$4,950USD£3,806GBP
- Report
- September 2025
- 150 Pages
United States
From €5246EUR$5,950USD£4,575GBP
- Report
- August 2025
- 200 Pages
United States
From €2195EUR$2,490USD£1,914GBP
- Report
- September 2025
- 85 Pages
United States
From €3086EUR$3,500USD£2,691GBP
- Report
- January 2025
- 140 Pages
Asia Pacific
From €3527EUR$4,000USD£3,075GBP
- Report
- May 2025
- 85 Pages
United States
From €3086EUR$3,500USD£2,691GBP
- Report
- April 2025
- 142 Pages
North America
From €3042EUR$3,450USD£2,653GBP
- Report
- April 2025
- 163 Pages
Europe
From €3042EUR$3,450USD£2,653GBP
- Report
- April 2025
- 161 Pages
Asia Pacific
From €3042EUR$3,450USD£2,653GBP
- Report
- October 2025
- 87 Pages
United States
From €4276EUR$4,850USD£3,729GBP
- Report
- October 2025
- 98 Pages
Middle East
From €4276EUR$4,850USD£3,729GBP
- Report
- August 2025
- 80 Pages
Middle East, Africa
From €3042EUR$3,450USD£2,653GBP
- Report
- August 2025
- 98 Pages
Asia Pacific
From €3483EUR$3,950USD£3,037GBP
- Report
- August 2025
- 101 Pages
Europe
From €3483EUR$3,950USD£3,037GBP
- Report
- August 2025
- 90 Pages
North America
From €3042EUR$3,450USD£2,653GBP
- Report
- June 2025
- 88 Pages
North America
From €3042EUR$3,450USD£2,653GBP
- Report
- June 2025
- 98 Pages
Europe
From €3483EUR$3,950USD£3,037GBP
- Report
- August 2019
- 264 Pages
Global
From €3522EUR$3,995USD£3,072GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more